A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer
Colorectal cancer (CRC) is the third most common malignancy across the globe and, despite advances in treatment strategies, survival rates remain low. Rectal cancer (RC) accounts for most of these cases, and traditional management strategies for advanced disease include total neoadjuvant therapy (TN...
Main Authors: | Lydia Melissourgou-Syka, Michael A. Gillespie, Sean M. O'Cathail, Owen J. Sansom, Colin W. Steele, Campbell S. D. Roxburgh |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2023-11-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-23-10 |
Similar Items
-
Influence of neoadjuvant radiotherapy combined with immunotherapy on minimally invasive surgeries for rectal cancer
by: YANG Yingchi, PANG Kai, ZHANG Zhongtao
Published: (2023-05-01) -
Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
by: Catherine R. Hanna, et al.
Published: (2021-05-01) -
Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies
by: Michael A. Gillespie, et al.
Published: (2021-06-01) -
A Population-Based Study of Secondary Prostate Cancer Risk after Radiotherapy in Male Patients with Rectal Cancer: A Retrospective Cohort Study
by: Jen-Pin Chuang, et al.
Published: (2019-04-01) -
Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial
by: Laura Kairevičė, et al.
Published: (2017-01-01)